主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMVT
#1145
Immunovant, Inc. Common Stock
27.730
0
+3.28%
版块:
基础:
利润货币:
日范围
年范围
日变化
+3.28%
每月变动
+3.47%
6个月变化
+44.35%
年变化
+44.35%
前一天收盘价
26.850
0
Open
27.730
0
Bid
Ask
Low
27.730
0
High
27.730
0
交易量
113
市场
股票
医疗保健
IMVT
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
新闻
Immunovant stock hits 52-week high at 28.32 USD
Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?
Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus
Immunovant股票创历史新高达27.87美元
Immunovant stock hits all-time high at 27.87 USD
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript
Immunovant股价跳涨7%,第三季度亏损收窄,优于预期
Immunovant shares jump 7% as Q3 loss narrows, beats estimates
Philip Morris, Biogen, Telenor, and more set to report earnings Friday
Immunovant earnings up next as Graves’ disease optimism builds